Novavax Inc NVAX:NASDAQ

RT Quote | Last NYSE Arca, VOL From CTA | USD
after hours iconAfter Hours: Last | 06/18/21 EDT
174.11quote price arrow down-0.30 (-0.17%)
Volume
95,122
Close
174.41quote price arrow down-5.48 (-3.05%)
Volume
2,736,795
52 week range
55.02 - 331.68

...

Loading . . .
  • Open177.01
  • Day High179.58
  • Day Low170.51
  • Prev Close179.89
  • 52 Week High331.68
  • 52 Week High Date02/09/21
  • 52 Week Low55.02
  • 52 Week Low Date06/18/20

Key Stats

  • Market Cap12.922B
  • Shares Out74.09M
  • 10 Day Average Volume5.13M
  • Dividend-
  • Dividend Yield-
  • Beta1.56
  • YTD % Change56.41

KEY STATS

  • Open177.01
  • Day High179.58
  • Day Low170.51
  • Prev Close179.89
  • 52 Week High331.68
  • 52 Week High Date02/09/21
  • 52 Week Low55.02
  • 52 Week Low Date06/18/20
  • Market Cap12.922B
  • Shares Out74.09M
  • 10 Day Average Volume5.13M
  • Dividend-
  • Dividend Yield-
  • Beta1.56
  • YTD % Change56.41

RATIOS/PROFITABILITY

  • EPS (TTM)-9.25
  • P/E (TTM)-18.85
  • Fwd P/E (NTM)-47.24
  • EBITDA (MRQ)-596.177M
  • ROE (MRQ)-121.19%
  • Revenue (MRQ)919.45M
  • Gross Margin (MRQ)-
  • Net Margin (MRQ)-66.90%
  • Debt To Equity (MRQ)44.29%

EVENTS

  • Earnings Date08/09/2021
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Related Video

VIDEO1:5301:53
Potential 4th Covid vaccine as Novavax phase three results show the vaccine is safe

Profile

MORE
Novavax, Inc. is a clinical-stage vaccine company focused on the discovery, development and commercialization of recombinant nanoparticle vaccines and adjuvants. The Company operates through developing recombinant vaccines segment. The Company, through its recombinant nanoparticle vaccine technology, produces vaccine candidates to respond to both known and newly emerging diseases. The Company's product pipeline focuses on a range of infectious diseases with vaccine candidates...
James Young Ph.D.
Chairman
Stanley Erck
President
Rick Crowley
Chief Operating Officer
John Trizzino
Chief Financial Officer
Troy Morgan J.D.
Executive Vice President
Address
21 Firstfield Rd
Gaithersburg, MD
20878-1757
United States